obl-raion.ru


ATHX STOCK

Athersys Stock News · Athersys Reports Third Quarter Financial Results and Business Highlights · Are Longevity Stocks the Next Trillion-Dollar Industry? You can watch ATHX and buy and sell other stock and options commission-free on Robinhood. Change the date range, see whether others are buying or selling. The Athersys, Inc. stock price is currently $ with a total market cap valuation of $ , (M shares outstanding). The Athersys, Inc. is trading. Athersys (ATHX) Ownership Overview The ownership structure of Athersys (ATHX) stock is a mix of institutional, retail and individual investors. Approximately. Athersys, Inc.: Delayed Quote, intraday chart, variations, volumes, technical indicators and last transactions, Stock Athersys, Inc. | OTC Markets: ATHX.

Athersys (ATHX) Stock Price Performance. License Error: Access from crawling bot. More on Forbes. 1 hour ago. Real Madrid Coach Ancelotti Addresses Modric Snub. Common Stock, par value $ per share, ATHX, The Nasdaq Stock Market LLC. Indicate by check mark whether the registrant is an emerging growth company as. Research Athersys' (OTCPK:ATHX.Q) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange. Athersys Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Athersys (ATHX) Stock Plummets to Week Low as Stroke Therapy Fails Mid-Stage Trial. Shares of Athersys (ATHX) plunged more than 55% to a one-year low of Athersys, Inc.'s stock symbol is ATHXQ and currently trades under OTCMKTS. It's current price per share is approximately $ When is Athersys, Inc.'s next. The average twelve-month price prediction for Athersys is $ with a high price target of $ and a low price target of $ Learn more on ATHX's analyst. Athersys stock quote and ATHX charts. Latest stock price today and the US' most active stock market forums.

Instrument Name Athersys Inc Instrument Symbol (ATHX). Instrument Exchange OTC US · Athersys to Participate in Three Upcoming Conferences · Athersys to. Athersys Stock Tumbles as Much as % on a Public Offering The stem cell developer decided to wisely take advantage of a soaring share price to raise funds. Stock analysis for Athersys Inc (ATHX:US) including stock price, stock chart, company news, key statistics, fundamentals and company profile. A list of the latest Athersys Inc News - ATHX Stock News, Press Releases, Earnings Report, Financial Disclosures, Offerings, Acquisitions. View today's Athersys Inc stock price and latest ATHXQ news and analysis. Create real-time notifications to follow any changes in the live stock price. Pre-market stock movers are a hot topic on Wednesday morning and we're covering all of the latest news investors need to know about! William White on. Athersys' stock was trading at $ at the beginning of Since then, ATHX shares have decreased by % and is now trading at $ View the best. ATHX - Athersys, Inc. Stock - Share Price, Short Interest, Short Squeeze, Borrow Rates (OTCPK). Yahoo · Athersys, Inc. (ATHX) stock forecast and price target. Find the latest Athersys, Inc. ATHX analyst stock forecast, price target.

Athersys (PK) stock quote and ATHX charts. Latest stock price today and the US' most active stock market forums. Click here for our free guide on how to buy Athersys Stock. As of the end of day on the , the price of an Athersys (ATHX) share was $ ATHX - Athersys, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (OTCPK) (). (OTC: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) cell therapy for critical care indications, announced financial results fo. View Athersys (ATHX) stock price, news, historical charts, analyst ratings, financial information and quotes on Futubull. Trade commission-free with the.

best budget mining gpu | sxsw price

7 8 9 10 11


Copyright 2014-2024 Privice Policy Contacts